Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.
Does finerenone improve outcomes in patients withheart failure (HF) with mildly reduced or preserved ejection fraction?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback